TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Accounts Payables (2019 - 2026)

TAO Synergies' (TAOX) quarterly Accounts Payables came in at $899175.0 in Q2 2026, little changed on a YoY basis from $898153.0 in Q2 2025, and down 4.98% quarter-over-quarter from $946327.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Accounts Payables (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Accounts Payables for 8 consecutive years, with $899175.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables changed 0.11% year-over-year to $899175.0; the trailing twelve-month figure through Jun 2026 stood at $899175.0 (changed 0.11% YoY), and the FY2025 full-year result was $1.2 million, up 270.43% from the prior year.
  • Accounts Payables retreated to $899175.0 in Q2 2026 per TAOX's latest filing, from $946327.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.2 million in Q4 2025 and bottomed at $114181.0 in Q1 2025.
  • Historically, Accounts Payables has averaged $532243.9 across 5 years, with a median of $441890.0 in 2023.
  • The sharpest annual moves came in 2022 and 2026: Accounts Payables sank 56.67% in 2022, then soared 728.8% in 2026.
  • Over 5 years, Accounts Payables stood at $660206.0 in 2022, then slumped by 32.65% to $444633.0 in 2023, then dropped by 28.64% to $317287.0 in 2024, then surged by 270.43% to $1.2 million in 2025, then slipped by 23.5% to $899175.0 in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $899175.0, $946327.0, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn 25.08 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn - 899,175.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 899,175.00
Mar 31, 2026 946,327.00
Dec 31, 2025 1.18 Mn
Sep 30, 2025 949,650.00
Jun 30, 2025 898,153.00
Mar 31, 2025 114,181.00
Dec 31, 2024 317,287.00
Sep 30, 2024 286,350.00
Jun 30, 2024 475,330.00
Mar 31, 2024 238,905.00
Dec 31, 2023 444,633.00
Sep 30, 2023 214,218.00
Jun 30, 2023 439,147.00
Mar 31, 2023 355,901.00
Dec 31, 2022 660,206.00
Sep 30, 2022 483,390.00
Jun 30, 2022 280,865.00
Mar 31, 2022 401,349.00
Dec 31, 2021 1.30 Mn
Sep 30, 2021 935,376.00